摘要
溶血性尿毒综合征(HUS)是移植肾功能障碍的一个少见原因,治疗困难、预后不良。肾移植术后的HUS包括原发HUS的复发和新发HUS两类,后者主要为药物(免疫抑制剂环孢素A和他克莫司、抗血小板药物氯吡格雷等)引起。新发HUS的主要高危因素是感染、急性排斥反应和免疫抑制剂浓度过高。治疗方法主要有:停用诱发药物、调整免疫抑制方案、血浆置换、输注新鲜冰冻血浆和抗凝治疗等。
出处
《国际泌尿系统杂志》
2006年第1期80-83,共4页
International Journal of Urology and Nephrology
参考文献27
-
1Bren A,Pajek J,Grego K,et al.Follow- up of kidney graft recipients with cyclosporine - associated hemolytic - uremic syndrome and thrombotic microangiopathy.Transplant Proc ,2005,37:1889 - 1891.
-
2Grupp C,Schmidt F,Braun F,et al.Haemolytic uraemic syndrome (HUS) during treatment with cyclosporin A after renal transplantation-is tacrolimus the answer? Nephrol Dial Transplant,1998,13:1629-1631.
-
3Franz M,Regele H,Schmaldienst S,et al.Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients:advantage of FK506 therapy? Transplantation,1998,66:1258 - 1262.
-
4Lin CC,King KL,Chao YW,et al.Tacrolimus - associated hemolytic uremic syndrome:a case analysis.J Nephrol,2003 ,16 :580 - 585.
-
5Gatti S,Arru M,Reggiani P,et al.Successful treatment of hemolytic uremic syndrome after liver -kidney transplantation.J Nephrol,2003,16:586 - 590.
-
6Langer RM,Van Buren CT,Katz SM,et al.De noro hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine - sirolimus combination.Transplantation,2002,73:756 - 760.
-
7Franco A,Hernandez D,Capdevilla L,et al.De novo hemolytic -uremic syndrome/thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors:role of sirolimus.Transplant Proc,2003,35:1764 - 1766.
-
8Egidi MF,Cowan PA,Naseer A,et al.Conversion to sirolimus in solid organ transplantation:a single - center experience.Transplant Proc,2003,35 :S131 - 137.
-
9Chiurchiu C,Ruggenenti P,Remuzzi G.Thrombotic microangiopathy in renal transplantation.Ann Transplant ,2002,7:28 - 33.
-
10Evens AM,Kwann HC,Kaufman DB,et al.TTP/HUS occurring in a simultaneous pancreas/kidney transplant recipient after clopidogrel treatment:evidence of a nonimmunological etiology.Transplantation,2002,74:885 - 887.
同被引文献31
-
1<环孢素A在肾内科的应用>专家协作组.环孢素A治疗肾小球疾病的应用共识[J].中华肾脏病杂志,2005,21(9):556-557. 被引量:74
-
2Goplani KR,Vanikar AV,Shah PR.Postrenal transplant hemolytic uremic syndrome/thrombotic microangiopathy:Ahmedabad experience.Transplant Proc.2008;40(4):1114-1116.
-
3Zarifian A,Meleg-Smith S,O'donovan R,et al.Cyclosporine-associated thrombotic microangiopathy in renal allografts.Kidney Int.1999; 55 (6):2457-2466.
-
4Lin CC,King KL,Chao YW,et al.Tacrolimus-associated hemolytic Uremic syndrome:a case analysis.J Nephrol.2003;16(4):580-585.
-
5Saikali J,Truong L,Suki W.Sirolimus may promote thrombotic microangiopathy.Am J Transplant.2003; 3(2):229-230.
-
6Sartelet H,Toupance O,Lorenzato M,et al.Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys.Am J Transplant.2005; 5(10):2441-2447.
-
7Le Quintrac M,Lionet A,Kamar N,et al.Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.Am J Transplant.2008;8(8):1694-1701.
-
8Cruzado JM,de Córdoba SR,Melilli E,et al.Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor Ⅰ and MCP.Am J Transplant.2009;9(6):1477-1483.
-
9Chan MR,Thomas CP,Torrealba JR,et al.Recurrent atypical hemolytic uremic syndrome associated with factor Ⅰ mutation in a living related renal transplant recipient.Am J Kidney Dis.2009; 53(2):321-326.
-
10Davin JC,Strain L,Goodship TH.Plasma therapy in atypical haemolytic uremic syndrome:lessons from a family with a factor H mutation.Pediatr Nephrol.2008;23(9):1517-1521.
引证文献2
-
1王金国,王娜,周洪澜,王伟刚,陈博,傅耀文.他克莫司替换环孢素A治疗溶血性尿毒综合征1例[J].中国组织工程研究与临床康复,2010,14(5):903-905.
-
2无,邵晓珊,蒋新辉,胡坚,杨锡强.儿童免疫相关性疾病临床实用热点问题专家建议系列之三——环孢素在中国儿童免疫相关疾病中的应用建议[J].中国实用儿科杂志,2020,35(6):417-423. 被引量:4
二级引证文献4
-
1马祝悦,顾婕,袁红宇.我院PASS系统前置审核规则优化探讨——以钙调磷酸酶抑制剂为例[J].中国药房,2021,32(18):2271-2276. 被引量:5
-
2中国医师协会皮肤科医师分会自身免疫病专业委员会,郭庆.环孢素治疗免疫相关性皮肤病专家建议[J].中华皮肤科杂志,2022,55(6):471-479. 被引量:7
-
3蒋志敬,薛桐,曲辉.钙调磷酸酶抑制剂治疗难治性川崎病的应用进展[J].儿科药学杂志,2023,29(5):57-60.
-
4孙文利,王红春,李梦,刘瑞,赵颖,郭进艳,卢光泽,刘红星,王磊.环孢素血药浓度监测在异基因造血干细胞移植患者中的应用[J].中国新药与临床杂志,2024,43(10):772-778.
-
1李培睿,胡明亮,王铁萍.溶血性尿毒综合征[J].中国冶金工业医学杂志,2000,17(2):127-128.
-
2汤小苏.溶血性尿毒症综合征7例临床分析[J].交通医学,2003,17(3):271-271.
-
3樊均明,李孜.溶血性尿毒综合征的诊断和治疗[J].新医学,2003,34(8):513-514. 被引量:2
-
4钱桂秋,韩霞.溶血性尿毒综合征1例报告[J].中原医刊,2003,30(21):46-46.
-
5傅鹏,刘随意,湛先宝,赵慧,崔若兰.重症急性胰腺炎并溶血尿毒症综合征一例报告[J].临床肾脏病杂志,2009(6):271-271.
-
6张磊,崔美玉,许冬梅,李文斌.溶血尿毒综合征复发1例分析[J].中国误诊学杂志,2008,8(34):8536-8536. 被引量:1
-
7高春林,刘光陵,夏正坤,傅元凤,伏洁,高远赋,张连丰,樊忠民,任献国.溶血尿毒综合征的临床与病理分析[J].天津医药,2007,35(8):606-607. 被引量:3
-
8王慧,徐敏,刘立林,贾丽丽,杨红萍,胡蝶,张青,吴婷婷,江雪.重症溶血尿毒综合征患儿的护理[J].中华护理杂志,2011,46(11):1130-1131. 被引量:4
-
9廖爱能,陈爱萍,钟鸿斌,吴文胜,金哲,王小华.易被忽视的肾衰竭病因——附80例分析[J].中华全科医师杂志,2008,7(4):262-263. 被引量:1
-
10李瑞娟.多途径综合救治溶血性尿毒综合征[J].中医研究,2009,22(8):46-48.